MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Efficacy of incobotulinumtoxinA in patients with sialorrhea, as assessed using the modified Radboud Oral Motor Inventory for Parkinson’s disease (mROMP): Results of the SIAXI study

    W. Jost, A. Friedman, O. Michel, C. Oehlwein, J. Slawek, A. Bogucki, S. Ochudlo, M. Banach, F. Pagan, B. Flatau-Baqué, J. Csikós, A. Blitzer (Wolfach, Germany)

    Objective: The pivotal double-blind, randomised Phase III SIAXI study (NCT02091739), assessed the efficacy and safety of incobotulinumtoxinA 75 or 100 U for sialorrhea. Co-primary endpoints…
  • 2018 International Congress

    Clinical features of Parkinson’s disease with and without rapid eye movement sleep behavior disorder

    Y. Liu, XY. Zhu, XJ. Zhang, Y. Feng, SH. Kuo, W. Ondo, YC. Wu (Shanghai, China)

    Objective: Study the relationship between RBD and other symptoms of PD. Background: Rapid eye movement sleep behavior disorder (RBD) and Parkinson’s disease (PD) are two…
  • 2018 International Congress

    Striatal dopamine transporter availability changes reflect gastrointestinal dysautonomia severity in early Parkinson’s disease

    J. Hinkle, K. Perepezko, K. Mills, Z. Mari, A. Butala, T. Dawson, A. Pantelyat, L. Rosenthal, G. Pontone (Baltimore, MD, USA)

    Objective: To test the hypothesis that constipation and gastrointestinal (GI) dysautonomia may be correlated with nigrostriatal dopaminergic (DA) dysfunction in PD. Background: Constipation is a…
  • 2018 International Congress

    Sensory signs and neuropathic pain in advanced Parkinson’s disease under levodopa treatment

    A.E. Elia, G. Devigili, M. Damasco, L.M. Romito, P. Soliveri, S. Rinaldo, M. Falsitta, R. Eleopra (Milan, Italy)

    Objective: To evaluate whether patients affected by Parkinson’s disease (PD) under levodopa/carbidopa intestinal gel (LCIG) therapy have alterations in sensory symptoms and signs and/or painful…
  • 2018 International Congress

    The Clinical Research of Parkinson’s Disease with Rapid Eye Movement Sleep Behavior Disorder

    Y. Wang, Z. Liang (Dalian, China)

    Objective: To compare the differences of clinical characteristics between PD patients with rapid eye movement sleep behavior disorder (RBD) (RBD+ group) and those without RBD…
  • 2018 International Congress

    Is Heart Rate variability a differential biomarker in REM sleep behavior disorder, Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy?

    F. Bernhard, G. Mayer, K. Kesper, A. Bauer, A. Janzen, E. Sittig, W. Cassel, D. Vadasz, N. Mix, V. Ries, W. Oertel (Marburg, Germany)

    Objective: Heart rate deceleration capacity (DC) and heart rate variability index (HRVI) as potential biomarkers for autonomic dysregulation were studied in subjects (each group N=10)…
  • 2018 International Congress

    Olfactory Hallucinations as a Non-motor sign of Parkinson’s disease – A cross-sectional study amongst patients in a tertiary movement center

    S. Chandra, M. Schiess, R. Mehanna (Houston, TX, USA)

    Objective: Assess the prevalence of olfactory hallucinations (OlfH) in patients presenting to a tertiary movement disorders outpatient clinic. Background: Hallucinations can be considered a non-motor…
  • 2018 International Congress

    Evaluation of Non-motor Symptoms of Parkinson’s Disease Patients in a Hong Kong Chinese population using the HK-NMSQuest

    V. Luk, N. Cheung, WC. Fong, G. Chan, A. Chan, KW. Fong, J. Lo, M. Ismail, J. Li, F. Chan, S. Chan, C. Chau, C. Ho, K.F. Leung, J. Lui, C. Wong, D. Chau, B. Chee, CW. Woo (Kowloon, Hong Kong)

    Objective: This study aimed to evaluate the non-motor symptom profiles of Hong Kong Chinese Parkinson’s Disease patients using the newly validated HK-NMSQuest, which is based…
  • 2018 International Congress

    Objective intestinal dysfunction in REM sleep behaviour disorder

    K. Knudsen, T. Fedorova, A. Hansen, M. Sommerauer, AM. Haase, M. Otto, K. Svendsen, K. Ostergaard, K. Krogh, P. Borghammer (Aarhus, Denmark)

    Objective: To study objectively measured intestinal function, defined by intestinal volume, transit times, and colonic motility patterns in patients with idiopathic REM sleep behaviour disorder…
  • 2018 International Congress

    Influence of dopamine deficiency on interhemispheric crosstalk in Parkinson’s disease

    P. Loehrer, F. Nettersheim, I. Weber, F. Jung, L. Timmermann (Marburg, Germany)

    Objective: To identify the significance of dopaminergic depletion in Parkinson’s disease (PD) on interhemispheric crosstalk using a complex bimanual tapping task. Background: Dopamine deficiency in…
  • « Previous Page
  • 1
  • …
  • 167
  • 168
  • 169
  • 170
  • 171
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley